Thursday 17 March 2016

Global Allergic Rhinitis Drugs Market Research And Report to 2020

http://www.radiantinsights.com/research/global-allergic-rhinitis-drugs-market-2016-2020
Allergic rhinitis is caused by the interaction of airborne allergens with specific immunoglobulin E (IgE) type antibodies on the surface of mast cells. This interaction causes mast cells to release and synthesize chemicals, causing inflammation of the surrounding tissues.

Typical symptoms include rhinorrhea, nasal itching, sneezing, and nasal congestion. Extranasal symptoms such as allergic conjunctivitis, itchy ears and palate, and asthma may also occur. Allergic rhinitis is treated using medications such as antihistamines, intranasal corticosteroids, or immunotherapies.

Alternative forms of treatment are also employed in certain cases. The report analysts forecast the global allergic rhinitis market to grow at a CAGR of 0.95% during the period 2016-2020.

Covered in this report:

The report covers the present scenario and the growth prospects of the global allergic rhinitis drugs market for the period 2016-2020. To calculate the market size, it considers revenue generated from the sales of prescription and off-label drugs used to treat allergic rhinitis.

The market is divided into the following segments based on geography:
  •  Americas
  •  APAC
  •  Europe
To Read other reports of this category:
http://www.radiantinsights.com/catalog/healthcare


Global Allergic Rhinitis Drugs Market has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  •  AstraZeneca
  •  GlaxoSmithKline
  •  Meda Pharmaceuticals
  •  Merck
  •  Sanofi
  •  UCB
Other prominent vendros
  •  Adamis Pharmaceuticals
  •  Alcon
  •  Alergo Pharma
  •  ALK-Abello
  •  Allergy Therapeutics
  •  Almirall
  •  Ampio
  •  Anergis
  •  Apotex
  •  Ares Life Sciences
  •  Array BioPharma
  •  Aspen Pharmacare
  •  Atopix Therapeutics
  •  Barr Laboratories
  •  Belcher Pharmaceuticals
  •  Circassia Pharmaceuticals
  •  Dainippon Sumitomo
  •  DBV Technologies
  •  Dr Reddy's Laboratories
  •  Eddingpharm
  •  Genentech
  •  Greer Laboratories
  •  Hanmi Pharmaceuticals
  •  Hisamitsu Pharmaceutical
  •  Intas Pharmaceuticals
  •  Kyowa Hakko
  •  Lupin Pharmaceuticals
  •  Mitsubishi Tanabe Pharma
  •  Mylan
  •  Nektar Therapeutics
  •  Novartis
  •  Nuvo Research
  •  Nycomed
  •  Omega Pharma
  •  Ono Pharmaceuticals
  •  Pfizer
  •  Revance Therapeutics
  •  Roxane Laboratories (Boehringer Ingelheim)
  •  Shionogi
  •  Stallergenes
  •  Sun Pharmaceuticals
  •  Takeda Pharmaceutical
  •  Teva Pharmaceuticals
  •  Verona Pharma
  •  VentiRx Pharmaceuticals
Market driver
  •  Increased prevalence of allergic rhinitis
  •  For a full, detailed list, view our report
Market challenge
  •  Patent expiries and competition from generic drugs
  •  For a full, detailed list, view our report
Market trend
  •  Increased R&D
  •  For a full, detailed list, view our report
Key questions answered in this report
  •  What will the market size be in 2020 and what will the growth rate be?
  •  What are the key market trends?
  •  What is driving this market?
  •  What are the challenges to market growth?
  •  Who are the key vendors in this market space?
  •  What are the market opportunities and threats faced by the key vendors?
  •  What are the strengths and weaknesses of the key vendors?

No comments:

Post a Comment